Analyst Research

Report Title Price
Provider: ValuEngine, Inc.
Provider: Ford Investor Services, Inc.
Provider: Reuters Investment Profile
Provider: Reuters Investment Profile

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

UPM-Kymmene Corporation to Collaborate with Ashland Inc on Application Development for UPM Biofibrils Technology

Sunday, 16 Jun 2013 08:00pm EDT 

UPM-Kymmene Corporation announced that the Company and Ashland Inc. have entered into a cooperative agreement to develop and commercialize products containing UPM’s Biofibrils technology. UPM Biofibrils are micro and nanofibrillated cellulose products that can be used for shaping materials and giving them new characteristics. In the biofibrils collaboration UPM and Ashland will jointly study the use of biofibrils in a wide range of industrial application opportunities. 

Company Quote

0.3 +2.50%
10:23am EDT